KROS Stock Risk & Deep Value Analysis

Keros Therapeutics, Inc.

Healthcare • Biotechnology

DVR Score

8.7

out of 10

Hidden Gem

The Bottom Line on KROS

We analyzed Keros Therapeutics, Inc. using our deep value framework. Sign in to see our full verdict and DVR Score.

We ran KROS through our deep value framework — analyzing financial health, distress signals, competitive moat, and risk factors. Here's what we found.

Updated Oct 4, 2025•Run Fresh Analysis →

About Keros Therapeutics, Inc. (KROS)

Sector

Healthcare

Industry

Biotechnology

Market Cap Category

small

Market Cap

$647.41M

KROS Deep Value Analysis

Keros Therapeutics exhibits significant 10x potential through its deep pipeline targeting large unmet medical needs via the TGF-beta pathway. Strong cash runway supports multiple near-term Phase 2/3 data readouts (KER-050, KER-012), which are major catalysts. Despite competition, differentiated mechanisms offer upside. Leadership is experienced, and capital allocation is sound. Key risks are inherent clinical trial failures, but the robust pipeline and strong financial position mitigate this. No significant 'dud' red flags identified, making it a high-risk, high-reward opportunity.

KROS Financial Health Metrics

Market Cap

$647.41M

P/E Ratio

49.81

📊 Explore More Stock Analysis

Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential.

Analyze Any Stock →View Top 100 Deep Value Stocks →

Important Disclaimer – Not Financial Advice

Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.

All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research and consult with a qualified financial advisor.

More Resources to Boost Your Portfolio

Explore our other guides and tools to maximize your investment returns